Italian guidelines for staging and follow-up of stage I-II cutaneous melanoma patients

Giornale Italiano di Dermatologia e Venereologia

Volumn 142, Issue 1, 2007, Pages 41-47

  Quaglino, P ^a   Borgognoni, L ^b   Bottoni, U ^c   Calvieri, S ^d   Carli, P ^e   Catricala C ^f   Eibenschutz, L ^f   Manganoni, A ^g   Moretti, S ^e   Pellacani, G ^h   Pimpinelli, N ^e   Seidenari, S ^h   Bernengo, M G ^a,i  

^a UNIVERSITY OF TURIN   (Italy)

^b SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e UNIVERSITY OF FLORENCE   (Italy)

^f SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

^g UNIVERSITY OF BRESCIA   (Italy)

^h UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

ⁱ UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER STAGING; EPILUMINESCENCE MICROSCOPY; FOLLOW UP; HUMAN; ITALY; MELANOMA; PRACTICE GUIDELINE; REVIEW; SKIN CANCER;

EID: 34247251412     PISSN: 03920488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Thompson JF, Scolyer RA, Kefford RF. Cutaneous melanoma. Lancet 2005;365:687-701.
2. de Vries E, Bray FI, Eggermont AM, Coebergh JW; European Network of Cancer Registries. Monitoring stage-specific trends in melanoma incidence across Europe reveals the need for more complete information on diagnostic characteristics. Eur J Cancer Prev 2004;13:387-95.
3. Rosso S, Budroni M. Skin cancers: melanoma, non-melanoma cancers and Kaposi's sarcoma. Epidemiol Prev 2004;28(2 Suppl):57-63.
4. De Vries E, Coebergh JW. Cutaneous malignant melanoma in Europe. Eur J Cancer 2004;40:2355-66.
5. AIRT Working Group. Italian cancer figures-report 2006: 1. Incidence, mortality and estimates. Epidemiol Prev 2006;30(1 Suppl 2):8-10, 12-28, 30-101 passim.
6. Carli P, De Giorgi V, Palli D, Maurichi A, Mulas P, Orlandi C et al. Dermatologist detection and skin self-examination are associated with thinner melanomas: results from a survey of the Italian Multidisciplinary Group on Melanoma. Arch Dermatol 2003;139:607-12.
7. Seidenari S, Pellacani G, Pepe P. Digital videomicroscopy improves diagnostic accuracy for melanoma. J Am Acad Dermatol 1998;39:175-81.
8. Carli P, De Giorgi V, Crocetti E, Mannone F, Massi D, Chiarugi A et al. Improvement of malignant/benign ratio in excised melanocytic lesions in the 'dermoscopy era': a retrospective study 1997-2001. Br J Dermatol 2004;150:687-92.
9. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
10. Ben-Porat L, Panageas KS, Hanlon C, Patel A, Halpern A, Houghton AN et al. Estimates of stage-specific survival are altered by changes in the 2002 American Joint Committee on Cancer staging system for melanoma. Cancer 2006;106:163-71.
11. Leiter U, Buettner PG, Eigentler TK, Garbe C. Prognostic factors of thin cutaneous melanoma: an analysis of the central malignant melanoma registry of the German Dermatological Society. J Clin Oncol 2004;22:3660-7.
12. Kalady MF, White RR, Johnson JL, Tyler DS, Seigler HF. Thin melanomas: predictive lethal characteristics from a 30-year clinical experience. Ann Surg 2003;238:528-37.
13. Zettersten E, Sagebiel RW, Miller JR, Tallapureddy S, Leong SP, Kashani-Sabet M. Prognostic factors in patients with thick cutaneous melanoma (> 4 mm). Cancer 2002;94:1049-56.
14. Soong SJ, Shaw HM, Balch CM, McCarthy WH, Urist MM, Lee JY. Predicting survival and recurrence in localised melanoma: a multivariate approach. World J Surg 1992;16:191-5.
15. Meier F, Will S, Ellwanger U, Schlagenhauff B, Schittek B, Rassner G et al. Metastatic pathways and time courses in the orderly progression of cutaneous melanoma. Br J Dermatol 2002;147:62-70.
16. Bernengo MG, Quaglino P, Cappello N, Doveil GC, Fierro MT, Lisa F et al. Time course and pattern of first relapse in stage I-II primary cutaneous melanoma: a multivariate analysis of disease-free survival in an italian single institution patients' cohort followed-up over a 30-year period. G It Dermatol Venereol 2005;140:191-200.
17. Sober AJ, Chuang TY, Duvic M, Farmer ER, Grichnik JM, Halpern AC et al. Guidelines/Outcomes Committee. Guidelines of care for primary cutaneous melanoma. J Am Acad Dermatol 2001;45:579-586.
18. Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001;19:3622-34.
19. Garbe C, Paul A, Kohler-Spath H, Ellwanger U, Stroebel W, Schwarz M et al. Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: recommendations for an effective follow-up strategy. J Clin Oncol 2003;21:520-9.
20. Stam-Posthuma JJ, van Duinen C, Scheffer E, Vink J, Bergman W. Multiple primary melanomas. J Am Acad Dermatol 2001;44:22-7.
21. Machet L, Nemeth-Normand F, Giraudeau B, Perrinaud A, Tiguemounine J, Ayoub J et al. Is ultrasound lymph node examination superior to clinical examination in melanoma follow-up? A monocentre cohort study of 373 patients. Br J Dermatol 2005;152:66-70.
22. Saiag P, Bernard M, Beauchet A, Bafounta ML, Bourgault-Villada I, Chagnon S. Ultrasonography using simple diagnostic criteria vs palpation for the detection of regional lymph node metastases of melanoma. Arch Dermatol 2005;141:183-9.
23. Bottoni U, Izzo P, Richetta A, Mannooranparampil TJ, Devirgiliis V, Del Giudice M et al. S-100 serum level: a tumour marker for metastatic melanoma. Melanoma Res 2003;13:427-9.
24. Quaglino P, Savoia P, Osella-Abate S, Bernengo MG. RT-PCR tyrosinase expression in the peripheral blood of melanoma patients. Expert Rev Mol Diagn 2004;4:727-41.
25. Schmid-Wendtner MH, Baumert J, Schmidt M, Konz B, Holzel D, Plewig G et al. Late metastases of cutaneous melanoma: an analysis of 31 patients. J Am Acad Dermatol 2000;43:605-9.
26. Kim CJ, Reintgen DS, Balch CM; AJCC Melanoma Staging Committee. The new melanoma staging system. Cancer Control 2002;9:9-15.